Skin β-endorphin mediates addiction to UV light.
Level 5 - mechanism / opinion, no new human data
Preclinical animal and bench research with no human data
PubMed 24949966 · doi:10.1016/j.cell.2014.04.032
What was done
Rodents (including wild-type, beta-endorphin knockout mice, and mice lacking keratinocyte p53-mediated POMC induction) were exposed to low-dose UV radiation. Authors evaluated epidermal proopiomelanocortin (POMC) processing to beta-endorphin, plasma beta-endorphin levels, pain-related thresholds, somatic withdrawal signs upon pharmacologic opioid antagonism following chronic UV, and avoidance behaviors via conditioned place aversion.
What was found
Low-dose UV radiation coordinately synthesized beta-endorphin in skin and elevated rodent plasma levels. Pain-related thresholds increased post-exposure and were reversed by opioid antagonism. Pharmacologic opioid blockade after chronic UV exposure elicited physical withdrawal signs and conditioned place aversion. These behavioral and nociceptive effects were completely absent in beta-endorphin knockout mice and in mice lacking epidermal keratinocyte p53-mediated POMC induction. The abstract does not provide exact numerical values, effect sizes, or animal numbers.
Why it matters
This paper identifies a cutaneous neuroendocrine pathway linking UV-induced tanning responses to endogenous opioid release, offering a biological mechanism for addictive-like sun-seeking behavior that may drive skin cancer risk.
Limits
The study is restricted entirely to rodent and knockout mouse models; human validation is not demonstrated in the abstract. Quantitative sample sizes (n), UV dosimetric details, plasma concentrations, and statistical confidence intervals are not reported in the abstract.
Cited by
- supports Pro-opiomelanocortin (POMC) produced in response to UV light is cleaved into beta-endorphin.